To validate the significance of sex steroid hormones in leiomyomas of postmenopausal women, we examined the expression of hormone receptors, such as PRB, progesterone receptor A and B (PRAB), and estrogen receptor (ER). This evidence concerns the gene NR4A1 and leiomyoma.